Ask The Board
-
How Can I Prepare To Join And Serve On A Board Of Directors?
5/2/2022
See the answer from Allan Shaw, an independent board member, CalciMedica, consulting CFO, and special advisor.
-
How Can Digital Technology Improve The Treatment Of Neurological Disorders?
5/2/2022
See the answer from John Reynders, VP, R&D strategy, program management, data science at Alexion Pharmaceuticals.
-
Following The Approval Of Biogen’s Aduhelm, There Has Been Talk About “Reining In” The FDA’s Accelerated Approval Pathway. How Important Is Accelerated Approval For Rare Disease Drugs?
5/2/2022
See the answer from John Crowley, chairman and CEO of Amicus Therapeutics.
-
What Technologies Do You Anticipate Disrupting Vaccine Manufacturing And Why?
4/1/2022
See the answer from Jacks Lee, SVP global manufacturing and supply at Merck.
-
What Have Been The Most Valuable Lessons Learned Over The Past Two Years?
4/1/2022
See the answer from Anu Hans, VP of strategic initiatives at Janssen Supply Chain.
-
What Would You Say To An Executive Who States They Don’t Know How To Manage/Lead Millennials?
4/1/2022
See the answer from Mary Rose Keller, VP of clinical operations at Acrivon Therapeutics.
-
What Do You See As The Most Pressing Issue Biopharma Leaders Should Be Paying Attention To And Why?
3/1/2022
See the answer from John Lamattina, the former president of Pfizer R&D who is now a senior partner at PureTech Health.
-
Why Does Diversity In Clinical Trials Continue To Be A Challenge For Biopharma Companies, And What Thoughts/Ideas Do You Have On How To Overcome?
3/1/2022
See the answer from Mitchell Katz, Ph.D., VP, development operations at Ferring Pharmaceuticals.
-
What Industry-Related Political Legislation Are You Following Most Closely?
3/1/2022
See the answer from Tom DiLenge, senior partner for global public policy, regulatory and governmental strategy at Flagship Pioneering.
-
How Do You See The Current Revolution In Process Development And Manufacturing Of Cell And Gene Therapies Changing The Regulatory Landscape For Approvals Of Personalized Medicines?
2/1/2022
See the answer from Charlene Banard, the former global head of cell & gene therapy, technical operations at Novartis.